SAVARINO, EDOARDO VINCENZO
 Distribuzione geografica
Continente #
NA - Nord America 22.288
AS - Asia 4.018
EU - Europa 3.881
SA - Sud America 149
AF - Africa 60
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 3
Totale 30.413
Nazione #
US - Stati Uniti d'America 22.240
SG - Singapore 2.286
IT - Italia 1.358
CN - Cina 950
DE - Germania 575
FI - Finlandia 547
HK - Hong Kong 319
FR - Francia 290
GB - Regno Unito 271
RU - Federazione Russa 246
VN - Vietnam 215
SE - Svezia 160
NL - Olanda 141
BR - Brasile 109
IN - India 65
AT - Austria 64
UA - Ucraina 62
IE - Irlanda 53
TR - Turchia 24
CA - Canada 22
CI - Costa d'Avorio 19
MX - Messico 19
PH - Filippine 19
ID - Indonesia 18
PK - Pakistan 17
IR - Iran 15
EG - Egitto 14
JP - Giappone 14
KR - Corea 14
NO - Norvegia 14
ES - Italia 12
AU - Australia 11
PL - Polonia 11
CL - Cile 10
RO - Romania 10
CH - Svizzera 9
CO - Colombia 9
ET - Etiopia 9
PT - Portogallo 9
BE - Belgio 8
TW - Taiwan 8
AR - Argentina 7
IQ - Iraq 7
LT - Lituania 6
CZ - Repubblica Ceca 5
MK - Macedonia 5
NG - Nigeria 5
SA - Arabia Saudita 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
BG - Bulgaria 4
DK - Danimarca 4
JO - Giordania 4
PE - Perù 4
BD - Bangladesh 3
BY - Bielorussia 3
EC - Ecuador 3
EU - Europa 3
GR - Grecia 3
IL - Israele 3
LU - Lussemburgo 3
MY - Malesia 3
NZ - Nuova Zelanda 3
PY - Paraguay 3
RS - Serbia 3
VE - Venezuela 3
BH - Bahrain 2
CU - Cuba 2
GE - Georgia 2
HN - Honduras 2
HU - Ungheria 2
KE - Kenya 2
KH - Cambogia 2
LK - Sri Lanka 2
LS - Lesotho 2
LV - Lettonia 2
LY - Libia 2
MA - Marocco 2
UZ - Uzbekistan 2
ZA - Sudafrica 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AM - Armenia 1
BO - Bolivia 1
BW - Botswana 1
CY - Cipro 1
DZ - Algeria 1
JM - Giamaica 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MQ - Martinica 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
TG - Togo 1
TM - Turkmenistan 1
Totale 30.413
Città #
Fairfield 4.245
Woodbridge 2.097
Houston 1.959
Ashburn 1.611
Seattle 1.511
Cambridge 1.454
Wilmington 1.240
Ann Arbor 1.175
Chandler 1.134
Singapore 978
Boardman 668
San Diego 557
Santa Clara 531
Princeton 458
Medford 372
Helsinki 338
Hong Kong 308
Des Moines 293
Beijing 271
Roxbury 217
Dong Ket 205
Padova 188
Munich 186
Jacksonville 157
Milan 109
Nanjing 103
London 93
Rome 86
Nuremberg 67
New York 55
Dublin 48
Ogden 45
Falls Church 44
Lappeenranta 40
Nanchang 36
Shenyang 36
Norwalk 32
Los Angeles 30
Vienna 30
Jiaxing 29
Changsha 28
Hebei 28
Falkenstein 27
Guangzhou 27
Kharkiv 27
Tianjin 22
Kilburn 21
Shanghai 21
Pune 20
Abidjan 19
Indiana 19
Verona 19
Washington 18
Chicago 17
Florence 17
Venice 17
Bologna 16
Jinan 15
Naples 15
Redwood City 15
Borås 14
Genoa 14
Palermo 14
Zhengzhou 14
Amsterdam 13
Prescot 13
Council Bluffs 12
New Bedfont 12
São Paulo 12
Villafranca Padovana 12
Turin 11
Istanbul 10
Las Vegas 10
Chiswick 9
Foligno 9
Fort Wayne 9
Hounslow 9
Paris 9
Treviso 9
Vicenza 9
Abbiategrasso 8
Bergen 8
Berlin 8
Brescia 8
Campodarsego 8
Monza 8
San Francisco 8
Solihull 8
Acton 7
Cairo 7
Frankfurt am Main 7
Groningen 7
Islington 7
Manila 7
Moscow 7
Parma 7
Phoenix 7
Reggio Nell'emilia 7
Rockville 7
Tappahannock 7
Totale 23.816
Nome #
Updates to the modern diagnosis of GERD: Lyon consensus 2.0 349
The natural history of gastro-esophageal reflux disease: a comprehensive review 240
Effects of laparoscopic myotomy on the esophageal motility pattern of esophageal achalasia as measured by high-resolution manometry 207
Correlation between reflux burden, peristaltic function, and mucosal integrity in GERD patients 206
A 10-day levofloxacin-based therapy in patients with resistant Helicobacter pylori infection: a controlled trial. 191
Step-up empiric elimination diet for pediatric and adult eosinophilic esophagitis: The 2-4-6 study 184
Esophagogastric junction morphology is associated with a positive impedance-pH monitoring in patients with GERD 165
The natural history of achalasia: Evidence of a continuum-"The evolutive pattern theory" 157
Superior Mesenteric Artery Syndrome: a Prospective Study in a Single Institution 156
The GerdQ questionnaire and high resolution manometry support the hypothesis that proton pump inhibitor-responsive oesophageal eosinophilia is a GERD-related phenomenon 146
Modern diagnosis of GERD: the Lyon Consensus 139
Effects of omega-loop bypass on esophagogastric junction function 134
The Chicago Classification of esophageal motility disorders, v3.0 131
Helicobacter pylori infection does not protect against eosinophilic esophagitis: results from a large multicenter case-control study 130
Achalasia and Obstructive Motor Disorders Are Not Uncommon in Patients With Eosinophilic Esophagitis 127
Noncoding RNAs as drivers of the phenotypic plasticity of oesophageal mucosa 126
Antimicrobial treatment with the fixed-dose antibiotic combination RHB-104 for Mycobacterium avium subspecies paratuberculosis in Crohn’s disease: pharmacological and clinical implications 120
OLGA Gastritis Staging for the Prediction of Gastric Cancer Risk: A Long-term Follow-up Study of 7436 Patients 120
Indications and interpretation of esophageal function testing 120
Practice guidelines on the use of esophageal manometry - A GISMAD-SIGE-AIGO medical position statement 119
Fecal calprotectin in systemic sclerosis: Light and shade of a promising tool 118
Normal values of 24-h ambulatory intraluminal impedance combined with pH-metry in subjects eating a Mediterranean diet. 116
Analyses of the Post-reflux Swallow-induced Peristaltic Wave Index and Nocturnal Baseline Impedance Parameters Increase the Diagnostic Yield of Impedance-pH Monitoring of Patients With Reflux Disease 116
Comment on "Impairment of chemical clearance is relevant to the pathogenesis of refractory reflux oesophagitis" by Marzio Frazzoni et al. [Digestive and Liver Disease 2014;46:596-602] 116
A comparison between sodium alginate and magaldrate anhydrous in the treatment of patients with gastroesophageal reflux symptoms. 114
Measurement of oro-caecal transit time by magnetic resonance imaging. 112
The Impact of Heller Myotomy on Integrated Relaxation Pressure in Esophageal Achalasia 112
Ambulatory reflux monitoring for diagnosis of gastro-esophageal reflux disease: Update of the Porto consensus and recommendations from an international consensus group 112
Clinical, endoscopic, histological and radiological characteristics of Italian patients with eosinophilic oesophagitis 112
Nonerosive reflux disease and functional heartburn are clearly separate entities. 111
Normal values of esophageal motility after antireflux surgery; a study using high-resolution manometry 111
Nonerosive reflux disease: Clinical concepts 111
Classification of esophageal motor findings in gastro-esophageal reflux disease: Conclusions from an international consensus group 110
A Comparison Between Lactose Breath Test and Quick Test on Duodenal Biopsies for Diagnosing Lactase Deficiency in Patients With Self-reported Lactose Intolerance. 109
Low serum trough levels are associated with post-surgical recurrence in Crohn's disease patients undergoing prophylaxis with adalimumab 109
Achalasia with dense eosinophilic infiltrate responds to steroid therapy. 107
Adalimumab trough levels and response to biological treatment in patients with inflammatory bowel disease: A useful cutoff in clinical practice 107
The appropriate use of proton pump inhibitors (PPIs): Need for a reappraisal 107
Optimal number of multiple rapid swallows needed during high-resolution esophageal manometry for accurate prediction of contraction reserve 107
Esophageal biopsies in the management of GERD: Complementary tool for many but not for all 106
Small intestinal bacterial overgrowth in patients suffering from scleroderma: clinical effectiveness of its eradication. 105
Influence of Diet on the Course of Inflammatory Bowel Disease 105
Innovative techniques in evaluating the esophagus; imaging of esophageal morphology and function; and drugs for esophageal disease. 104
REAL LIFE COMPARISON OF DIFFERENT ANTI-TNF BIOLOGIC THERAPIES FOR ULCERATIVE COLITIS TREATMENT: A RETROSPECTIVE COHORT STUDY 104
Characteristics of reflux episodes and symptom association in patients with erosive esophagitis and nonerosive reflux disease: study using combined impedance-pH off therapy. 103
Granulo-monocyto apheresis is more effective in mild ulcerative colitis than in moderate to severe disease. 103
Proton pump inhibitor failure: why does it occur and how can it be managed? 102
Arterial congestive gastropathy: A new entity? 102
There is much more to rely on histology than the sole endoscopy tells us 102
Modulation of inflammation in IBD: Alpha7nAChR expression and role of nicotine 101
NERD: an umbrella term including heterogeneous subpopulations. 100
A modification of Nissen fundoplication improves patients’ outcome and may reduce procedure-related failure rate 100
The appropriate use of proton-pump inhibitors 100
Lactulose breath test to assess oro-cecal transit delay and estimate esophageal dysmotility in scleroderma patients. 99
Between GERD and NERD: the relevance of weakly acidic reflux 99
The added diagnostic value of postreflux swallow-induced peristaltic wave index and nocturnal baseline impedance in refractory reflux disease studied with on-therapy impedance-pH monitoring 99
Symptom association analysis is important in GERD patients undergoing endoscopic therapy 98
The placebo effect is a relevant factor in evaluating effectiveness of therapies in functional gastrointestinal disorders 98
In-vivo Axial-strain Sonoelastography Helps Distinguish Acutely-inflamed from Fibrotic Terminal Ileum Strictures in Patients with Crohn's Disease: Preliminary Results 98
Anti-Tumor Necrosis Factor Antibodies for Prevention of Crohn's Disease Recurrence After Surgery: More Than a Hope 98
Quality of life after laparoscopic sigmoid resection for uncomplicated diverticular disease 98
A safety review of proton pump inhibitors to treat acid-related digestive diseases 98
Microbiota changes induced by microencapsulated sodium butyrate in patients with inflammatory bowel disease 98
Combined multichannel intraluminal impedance and manometry testing. 98
Letter: proton pump inhibitor-responsive oesophageal eosinophilia – more than just gastro-oesophageal reflux disease. Authors' reply 97
The reason for failure of on-demand PPI therapy in NERD patients. 96
Functional Heartburn Overlaps With Irritable Bowel Syndrome More Often than GERD 96
A modified Nissen fundoplication: subjective and objective midterm results 96
Matrix Metalloproteinase 3 Predicts Therapeutic Response in Inflammatory Bowel Disease Patients Treated With Infliximab 96
Eosinophilic esophagitis: Latest insights from diagnosis to therapy 95
Gastrointestinal: An unusual rectal finding in a patient with ulcerative colitis 95
Expert consensus document: Advances in the physiological assessment and diagnosis of GERD 95
Helicobacter pylori and tolerance to H2-blockers. 94
Ultrasound assessment of the rotator cuff cable: comparison between young and elderly asymptomatic volunteers and interobserver reproducibility. 94
Non-erosive reflux disease patients are more complex than the sole endoscopy tells us. 94
Factors associated with disability in patients with ulcerative colitis: A cross-sectional study 94
Faecal microbiota transplantation in Clostridioides difficile infection: real-life experience from an academic Italian hospital 94
Functional testing: pharyngeal pH monitoring and high-resolution manometry. 93
A more in-depth evaluation of impedance-pH could assist in distinguishing reflux-related from reflux-unrelated heartburn 93
Ilaprazole for the treatment of gastro-esophageal reflux 93
Ultrasound-guided procedures around the wrist and hand: How to do. 93
Validation of criteria for the definition of transient lower esophageal sphincter relaxations using high-resolution manometry 92
Fecal microbiota transplantation for norovirus infection: a clinical and microbiological success. 92
A specific microbiota signature is associated to various degrees of ulcerative colitis as assessed by a machine learning approach 92
Current and future perspectives in the management of gastroesophageal reflux disease 91
Factors Influencing Disability and Quality of Life during Treatment: A Cross-Sectional Study on IBD Patients 91
Duodenal Histological Findings and Risk of Coeliac Disease in Subjects with Autoimmune Atrophic Gastritis: A Retrospective Evaluation 91
An evaluation of the antireflux properties of sodium alginate by means of combined multichannel intraluminal impedance and pH-metry. 90
Letter: treatment for small intestinal bacterial overgrowth - where are we now? 90
Infliximab trough levels and persistent vs transient antibodies measured early after induction predict long-term clinical remission in patients with inflammatory bowel disease 90
Weak Cytotoxic T Cells Activation Predicts Low-Grade Dysplasia Persistence in Ulcerative Colitis 90
Functional heartburn and non-erosive reflux disease. 89
Gastrointestinal motility disorder assessment in systemic sclerosis. 89
Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn's disease: a randomized controlled trial. 89
Long-Term Safety of In Utero Exposure to Anti-TNFα Drugs for the Treatment of Infl ammatory Bowel Disease: Results from the Multicenter European TEDDY Study 89
Association Between Baseline Impedance Values and Response Proton Pump Inhibitorsin Patients With Heartburn. 89
Updates in the field of non-esophageal gastroesophageal reflux disorder 89
The importance of subgrouping refractory NERD patients according to esophageal pH-impedance testing. 88
Are proton pump inhibitors really so dangerous? 88
Gastric fundal splenosis presenting as a stromal tumor and diagnosed by endoscopic ultrasound-guided SharkCore biopsy 88
Totale 11.217
Categoria #
all - tutte 153.572
article - articoli 153.349
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 306.921


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.718 0 0 0 0 0 0 0 0 547 608 385 178
2020/20214.284 368 152 369 334 187 302 385 364 567 479 294 483
2021/20226.157 284 611 666 364 607 304 403 589 544 170 478 1.137
2022/20233.013 732 132 91 352 424 407 28 189 335 57 201 65
2023/20242.499 125 245 207 177 173 211 209 167 141 100 374 370
2024/20256.397 53 714 556 330 1.301 338 642 1.065 1.398 0 0 0
Totale 31.120